Correlation Between Nuvalent and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Nuvalent and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Crinetics Pharmaceuticals.
Diversification Opportunities for Nuvalent and Crinetics Pharmaceuticals
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nuvalent and Crinetics is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Nuvalent i.e., Nuvalent and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Nuvalent and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Nuvalent is expected to generate 0.89 times more return on investment than Crinetics Pharmaceuticals. However, Nuvalent is 1.13 times less risky than Crinetics Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 9,363 in Nuvalent on August 25, 2024 and sell it today you would earn a total of 130.00 from holding Nuvalent or generate 1.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Nuvalent |
| Crinetics Pharmaceuticals |
Nuvalent and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Crinetics Pharmaceuticals
The main advantage of trading using opposite Nuvalent and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Nuvalent vs. Eliem Therapeutics | Nuvalent vs. HCW Biologics | Nuvalent vs. RenovoRx | Nuvalent vs. Scpharmaceuticals |
| Crinetics Pharmaceuticals vs. Eliem Therapeutics | Crinetics Pharmaceuticals vs. HCW Biologics | Crinetics Pharmaceuticals vs. RenovoRx | Crinetics Pharmaceuticals vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |